Introduction
Activation of cyclooxygenase (CO) and/or lipoxyygenase (LO) pathways of arachidonic acid metabolism generates lipid mediators with a multitude of pharmacological activities; several of these eicosanoids have been proposed to play a major role in human inflammatory diseases such as arthritis, asthma, psoriasis, ulcerative colitis and shock. 1 were used as indices of CO or 5-LO activity in vivo. Indomethacin attenuated A-23187 induced increases in 6-KPA levels without affecting levels of LTB 4. In contrast, zileuton, a selective 5-LO inhibitor, attenuated leukotriene biosynthesis is a dosedependent manner without inhibiting levels of the CO product, 6-KPA (Fig. 2) 
